内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Bredt David. Insider active across 1 company, notably Rapport Therapeutics, Inc.. In total, 13 filings have been recorded. Breakdown: 0 buy · 12 sells. Total volume traded: €1.3m. History available since 14 March 2025. The latest transaction was disclosed on 17 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bredt David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
900 股@ US$28.02111.7% 占其流量Common StockSEC:0001193125-26-059883:0
8,300 股@ US$26.825515.1% 占其流量Common StockSEC:0001193125-26-015350:0
18,000 股Common StockSEC:0001193125-26-002470:0
7,704 股@ US$29.946918.7% 占其流量Common StockSEC:0001193125-25-321142:0
3,156 股@ US$24.83997.9% 占其流量Common StockSEC:0001193125-25-286212:0
7,418 股@ US$25.732920.8% 占其流量Common StockSEC:0001193125-25-241475:0
5,098 股@ US$23.884116.6% 占其流量Common StockSEC:0001193125-25-206203:0
8,300 股@ US$14.976920.5% 占其流量Common StockSEC:0000950170-25-109838:0
8,500 股@ US$13.995524.8% 占其流量Common StockSEC:0000950170-25-096268:0
8,500 股@ US$11.002626.1% 占其流量Common StockSEC:0000950170-25-087897:0
8,500 股@ US$9.560231.6% 占其流量Common StockSEC:0000950170-25-074409:0
8,500 股@ US$9.565931.4% 占其流量Common StockSEC:0000950170-25-054819:0
8,500 股@ US$10.847737.0% 占其流量Common StockSEC:0000950170-25-040447:0
About Bredt David
Bredt David is a declarant linked to Rapport Therapeutics, Inc., where he serves as Chief Scientific Officer. He has 13 filings in total, and across the sampled recent filings between 2025-03-17 and 2026-02-19, the reported activity consists entirely of sales, for a total of EUR 1263600.